- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 26.06. | More than digital: prioritising the human element in HCP engagement design | ||
| 25.06. | MHRA becomes founding member of HealthAI Global Regulatory Network | ||
| 25.06. | J&J's Darzalex recommended by CHMP to treat smouldering multiple myeloma | ||
| 25.06. | EC approves argenx's subcutaneous Vyvgart for rare autoimmune disease CIPD | ||
| 25.06. | The value of Medscape Extend - redefining omnichannel engagement with physicians in Europe | ||
| 24.06. | AstraZeneca/Daiichi Sankyo's Datroway granted FDA accelerated approval for lung cancer | ||
| 24.06. | Eli Lilly shares promising phase 3 results for once-weekly insulin candidate efsitora alfa | ||
| 24.06. | Innovation with intention: balancing scientific progress and patient-centricity in oncology | ||
| 23.06. | PMGroup and Visions4Health launch Excellence in Healthcare Partnerships Awards | ||
| 23.06. | Sanofi/Regeneron's Dupixent granted FDA approval for bullous pemphigoid | ||
| 23.06. | First NHS patient treated with CSL Behring's haemophilia B gene therapy Hemgenix | ||
| 23.06. | Mitigating barriers to recruitment and retention in early stage Alzheimer's trials | ||
| 20.06. | Boehringer's Spevigo recommended by NICE for generalised pustular psoriasis | ||
| 20.06. | Ventyx's investigational NLRP3 inhibitor shows promise in Parkinson's disease | ||
| 20.06. | GCI Health appoints Aneeb Sharif as EMEA head of policy | ||
| 20.06. | Communicating with HCPs through AI takes finesse, flexibility and the human touch | ||
| 19.06. | Gilead Sciences' twice-yearly HIV PrEP drug Yeztugo granted FDA approval | ||
| 19.06. | FDA approves CSL's Andembry to prevent hereditary angioedema attacks | ||
| 19.06. | Galderma shares positive long-term data for Nemluvio in prurigo nodularis | ||
| 19.06. | Maximising the potential of AI in pharma | ||
| 19.06. | Local muscle, global impact | ||
| 18.06. | Eli Lilly to expand cardiovascular disease pipeline with $1.3bn Verve acquisition | ||
| 18.06. | FDA unveils new voucher programme to accelerate drug review process | ||
| 18.06. | AstraZeneca's Ultomiris shows promise in rare post-transplant complication | ||
| 18.06. | Achieving gender parity - designing clinical trials with women in mind |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .